Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Convolvulus althaeoides as a Potential Natural Source in Cancer Prophylaxis and Treatment: LC-ESI-MS/MS, GC-MS, In Vitro, and In Silico Investigations.

Created on 01 Oct 2026

Authors

Ahmed R Hassan, Shaimaa Negm El-Dein, Amany M Korkor, Nourelhoda F Hassan, Ahmed A M A Selim

Published in

Chemistry & biodiversity. Volume 23. Issue 10. Pages e71792.

Abstract

The current study aims to assess the potential relevance of the successive fractions, n-hexane and ethyl acetate (EtOAc) of Convolvulus althaeoides in cancer management. Our study demonstrated significant in vitro cytotoxic activity with IC50 values of 5.8, 2.5, and 2.8 for EtOAc and 7.1, 5.3, and 5.3 µg/mL for n-hexane against HepG-2, MCF-7, and HCT-116, respectively, comparable to doxorubicin (4.8, 5.6, and 6.5 µg/mL), with a higher IC50 against normal human cell line. EtOAc and n-hexane fractions exhibited substantial antioxidant using DPPH (97.22% and 90.12%, respectively) and moderate anti-inflammatory properties by HRBC method (34.95% and 41.9%, respectively). LC-ESI-MS/MS analysis of EtOAc fraction revealed 41 peaks with varied chemical structures, indicating its richness of phenolic compounds. GC-MS of n-hexane fraction indicated an abundance of noteworthy fatty acids, phytol, and phytosterols. The in silico results showed good pharmacophore features and docking scores for some of the identified compounds on ERR-3 (quercetin-3-O-pentoside -11.497), microtubule (rutin -10.801), and tubulin (quercetin-3-O-glucoside -7.113).

PMID:
42814524
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 23
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement